Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

Dow Jones

39,134.76

0.77%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that it has
granted, subject to regulatory approval, options to directors and officers of
the company exercisable to acquire an aggregate of 1,500,000 common shares, at a
price of $0.10 per share, expiring July 21, 2021.

Bradmer Pharmaceuticals (TSXV:BMR.H)
Gráfica de Acción Histórica
De May 2024 a Jun 2024